North Star Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$551K Sell
6,883
-12
-0.2% -$989 0.03% 361
2025
Q4
$588K Buy
6,895
+43
+0.6% +$3.53K 0.04% 313
2025
Q3
$533K Hold
6,852
0.03% 317
2025
Q2
$536K Sell
6,852
-30
-0.4% -$2.24K 0.04% 304
2025
Q1
$499K Hold
6,882
0.04% 316
2024
Q4
$509K Hold
6,882
0.04% 322
2024
Q3
$454K Hold
6,882
0.03% 330
2024
Q2
$636K Hold
6,882
0.05% 292
2024
Q1
$658K Hold
6,882
0.05% 293
2023
Q4
$525K Hold
6,882
0.04% 318
2023
Q3
$477K Hold
6,882
0.04% 331
2023
Q2
$649K Hold
6,882
0.05% 304
2023
Q1
$569K Buy
6,882
+6,000
+680% +$472K 0.05% 328
2022
Q4
$65.8K Buy
882
+30
+4% +$2.31K 0.01% 557
2022
Q3
$70K Hold
852
0.01% 486
2022
Q2
$81K Hold
852
0.01% 477
2022
Q1
$100K Hold
852
0.01% 467
2021
Q4
$110K Hold
852
0.01% 469
2021
Q3
$96K Hold
852
0.01% 479
2021
Q2
$88K Hold
852
0.01% 497
2021
Q1
$71K Buy
852
+612
+255% +$51.7K 0.01% 495
2020
Q4
$22K Hold
240
﹤0.01% 666
2020
Q3
$19K Hold
240
﹤0.01% 665
2020
Q2
$17K Hold
240
﹤0.01% 654
2020
Q1
$15K Hold
240
﹤0.01% 670
2019
Q4
$19K Hold
240
﹤0.01% 715
2019
Q3
$18K Buy
+240
New +$16.9K ﹤0.01% 722
2019
Q2
Sell
-240
Closed -$15K 563
2019
Q1
$15K Hold
240
﹤0.01% 760
2018
Q4
$12K Hold
240
﹤0.01% 769
2018
Q3
$14K Buy
+240
New +$11.7K ﹤0.01% 782

Other funds holding EW

North Star Investment Management's EW Position: Q1 2026 in Review

North Star Investment Management reduced its Edwards Lifesciences (EW) stake by 0.17% in Q1 2026, selling an estimated $989 and leaving 6,883 shares worth $551K. The position accounts for 0.03% of the portfolio, ranked #361.

North Star Investment Management first reported a position in EW in Q3 2018 and has held it in 30 quarters since. The position peaked at $658K in Q1 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • North Star Investment Management held 6,883 shares of Edwards Lifesciences worth $551K as of Q1 2026.
  • North Star Investment Management sold 12 Edwards Lifesciences shares in Q1 2026, an estimated $989.
  • Edwards Lifesciences made up 0.03% of North Star Investment Management's portfolio in Q1 2026, its #361 holding.
  • North Star Investment Management first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 30 quarters since.
  • North Star Investment Management's Edwards Lifesciences position peaked at $658K in Q1 2024.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.